MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at StockNews.com from a "sell" rating to a "buy" rating.
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.
MacroGenics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics, Inc. (NASDAQ: MGNX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.